key: cord-0792687-ngeo7bpj
authors: Rhoades, Nicholas S.; Pinski, Amanda; Monsibais, Alisha N.; Jankeel, Allen; Doratt, Brianna M.; Cinco, Isaac R.; Ibraim, Izabela; Messaoudi, Ilhem
title: Acute SARS-CoV-2 infection is associated with an expansion of bacteria pathogens in the nose including Pseudomonas Aeruginosa
date: 2021-05-20
journal: bioRxiv
DOI: 10.1101/2021.05.20.445008
sha: 28b11586337b5327058c24048895169c9d03841a
doc_id: 792687
cord_uid: ngeo7bpj

Much of the research conducted on SARS-CoV-2 and COVID-19 has focused on the systemic host response, especially that generated by severely ill patients. Very few studies have investigated the impact of acute SARS-CoV-2 within the nasopharynx, the site of initial infection and viral replication. In this study we profiled changes in the nasal microbial communities as well as in host transcriptional profile during acute SARS-CoV-2 infection using 16S amplicon sequencing and RNA sequencing. These analyses were coupled to viral genome sequencing. Our microbiome analysis revealed that the nasal microbiome of COVID patients was unique and was marked by an expansion of bacterial pathogens. Some of these microbes (i.e. Acinetobacter) were shared with COVID negative health care providers from the same medical center but absent in COVID negative outpatients seeking care at the same institutions suggesting acquisition of nosocomial respiratory pathogens. Specifically, we report a distinct increase in the prevalence and abundance of the pathogen Pseudomonas aeruginosa in COVID patients that correlated with viral RNA load. These data suggest that the inflammatory environment caused by SARS-CoV-2 infection and potentially exposure to the hospital environment leads to an expansion of bacterial pathogens in the nasal cavity that could contribute to increased incidence of secondary bacterial infections. Additionally, we observed a robust host transcriptional response in the nasal epithelia of COVID patients, indicative of an antiviral innate immune repones and neuronal damage. Finally, analysis of viral genomes did not reveal an association between viral loads and viral sequences.

infections. Additionally, we observed a robust host transcriptional response in the nasal epithelia 48 of COVID patients, indicative of an antiviral innate immune repones and neuronal damage. 49

Finally, analysis of viral genomes did not reveal an association between viral loads and viral 50 sequences. 51 52 53

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent 56 of coronavirus disease 2019 (COVID-19) and the cause of the ongoing global pandemic(1, 2). 57 COVID-19 is a respiratory disease ranging in clinical presentation from an asymptomatic (~80% 58 of cases) to a fatal infection (~1-2%) accompanied by cytokine storm, acute respiratory distress 59 syndrome and coagulopathy (3, 4). Long-term consequences of COVID-19 range from anosmia 60 and ageusia(3, 5, 6) to respiratory (e.g., dyspnea) and nervous system (e.g., headache, anosmia) 61 complications (7). Numerous studies have identified advanced age, comorbidities (notably, 62 obesity and diabetes), and biological sex as risk factors for severe 5, 8, 9) . Other 63 factors modulating disease, including mucosal microbial defenses and viral burden at the site of 64 pathogenesis have been under-explored. 65 SARS-CoV-2 is primarily spread through the inhalation of virus-laden respiratory 66 droplets(5). Initial replication occurs in the upper respiratory tract (URT) following the interaction 67 of the viral spike protein and host ACE2, and subsequent entry into cells (10-12). The nasal cavity 68 is believed to be the initial site of viral replication rather than the oral cavity due to higher 69 expression of ACE2 (13-15) and greater levels of viral RNA (vRNA) in this site compared to 70 matched oral specimens (16). Rapid and uncontrolled replication can lead to infection of the lower 71 respiratory tract (LRT) and severe disease. However, several studies have demonstrated a lack 72 of correlation between disease severity and viral RNA load in nasal cavities, suggesting that other 73 factors contribute to disease at the site of infection (17) (18) (19) . 74

Anaerococcus was enriched in CoV-outpatients, while Lawsonella and Burkholderia were most 217 abundant in CoV-HCW (Figure 2A, Supp Table 1 ). Finally, several pathogenic bacteria such as 218

Rothia, Acinetobacter, and Pseudomonas were most abundant in COV+ in-patients (Figure 2A , 219 Supp Table 1 ). To further explore the distribution of specific taxonomic groups, we plotted the 220 abundance of select taxa across all three groups. The two most abundant genera, 221

Corynebacterium and Staphylococcus were equally abundant in the groups (Figure 2B,C) . 222

Interestingly, relative abundance of Anoxybacillus was higher in both outpatients CoV-and CoV+ 223 inpatients compared to HCW ( Figure 2D) . Conversely, Burkholderia cepacia was significantly 224 more abundant in CoV-HCW (Figure 1F, 2E) . On the other hand, the genera Acinetobacter, and 225

Pseudomonas were most abundant in the COV+ inpatients (Figure 2 F, G) . When probed at the 226 species level, Pseudomonas aeruginosa was highly enriched in CoV+ inpatients ( Figure 2H) . 227

Taken together, these data suggest SARS-CoV-2 infection is associated with a shift in the nasal 228 microbiome and acquisition of pathobionts. when the relative abundance of taxa was taken into account, viral loads explained 10% of the 239 overall community composition (Supp Figure 1H , PERMANOVA p value<0.001). Moreover, the 240 nasal communities of patients with low and mid Ct groups were more similar to each other than 241 either group was to the high Ct (Supp Figure 1I) , suggesting that shifts in the nasal microbiome 242 associated with SARS-CoV-2 infection may be affected by vRNA load. 243 We next assessed differentially abundant genera between the 3 Ct groups (Figure 3) . 244

LefSe analysis showed that nasal microbial communities in patients with low vRNA loads were 245 had higher abundance of Streptococcus, while those of patients with moderate vRNA loads were 246 denoted by abundance of Corynebacterium, and those of patients with high vRNA loads by 247

Cutibacterium, Neisseria, and Pseudomonas ( Figure 3A) . The relative abundance of the genus 248

Streptococcus was highest in the high CT group (Figure 3B ), while that of Corynbacterium was 249 more abundant in the Mid and Low CT groups ( Figure 3C) . Finally, Neisseria and Pseudomonas 250 were more abundant in the low Ct group (Figure 3D,E) and Pseudomonas areuginosa was 251 positively associated with viral loads (Figure 3F) . 252

We compared the nasal transcriptomes of CoV-HCW and CoV+ inpatients using RNA-255

Seq to understand changes in host responses to infection (Figure 4) . We idenitifed a total of 692 256 differentially expressed genes (DEGs) between the two groups (n=377 upregulated, n=315 257 downregulated) in the CoV+ group ( Figure 4A) . Functional enrichment showed that upregulated 258 DEGs enriched to multiple Gene Ontology (GO) terms associated with innate and adaptive host 259 defense pathways such as "response to virus", and "inflammatory response", "response to 260 bacterium" and "lymphocyte activation" (Figure 4B) . A large number of interferon-stimulated 261 genes (ISGs; e.g., HERC5, IFITM3, ISG15, OAS2, RSAD2) and those related to type I interferon 262

signaling (e.g., IRF7, STAT1) mapped to these GO terms "response to virus" (Figure 4C ). Genes 263 with roles in NFKB and JUN-ATP-1 signaling, such as BCL3, JUN and MYD88, mapped to GO 264 terms "inflammatory response". In terms of cell-mediated immunity, expression of genes involved 265 in leukocyte chemotaxis (e.g., CCL2, CCL4, CXCL9, CCR1), hematopoiesis (e.g., CD53, IKZF1, 266 IKZF3, JAK3) and B cell activation (e.g., IGHA, LCK, ZAP70) were upregulated in CoV+ patients. 267

Interestingly, genes that encode inhibitory receptors (e.g.CD300E and LAGLS9) as well as genes 268 involved in cell death (e.g. BCL2, NUPR1 and ZBP1) were also highly upregulated. Additionally, 269 upregulated DEGs (e.g. SNCA, EGR1 and MDK) belonged to GO terms associated with cell 270 death, including "neuron death" (Figure 4B) . 271 Downregulated DEGs mapped to GO terms related to maintenance of homeostasis (e.g., 272

"response to wounding", "), cellular organization (e.g., "microtubule-based movement") and 273 neuronal tissue processes (e.g., "sensory organ development") ( Figure 4C ). Notable 274 downregulated DEGs encoded for integrins (e.g., ITGA2/3/V, ITGB1/6) laminins (e.g., 275

LAMA2/B2/B3/C2) and microtubules (e.g., DNAH3/7/10/11, DYNC2H1, WDR19) comprising 276 intracellular and extracellular structures like cilia and cell-cell adhesion junctions. We also 277 observed a downregulation of genes associated with mucin production in nasal passages (e.g., 278 MUC20, MUC5AC). Of the ion channels downregulated (e.g., ATP1A1, SLC39A), several were 279 involved in chloride ion balance and neuron homeostasis (e.g., CLCN3, CLCA1, SLC1A1, 280 SLC4A8) (Figure 4A, E) . 281 282

To identify potential relationships between vRNA load and viral evolution, we assembled 284 and characterized SARS-CoV-2 genomes from each CoV+ in-patient ( Figure 5) . Ct value was 285 negatively associated with viral genome coverage, with 100%, 74% and 13% of genomes from 286 Ct groups 10-20, 21-30 and 31-40 achieving greater than 90% genome coverage, respectively 287 ( Figure 5A ). All genomes with adequate coverage harbored the spike D614G and nsp12 P4715L 288 mutations ( Figure 5B ). One synonymous mutation in nsp3 (F924) was also present in all 289 genomes. The nucleoprotein T205I mutation associated with the 501.V2 variant was found in one 290 individual (Ct 31-40). Genomes from each Ct group belonged to three main clades 20A, 20B, and 291 20C with no distinct relation to current variants of concern (P.1, B. Hospital acquired infections (HAI) are a major public health concern. A recent multi-center 330 study found that 46% of patients hospitalized with COVID-19 suffered from a HAI (50). HAI are 331 often attributed to contamination associated with healthcare workers or hospital environments 332 (66). One of the major reservoirs for opportunistic pathogens is the nasal cavity which can act as identified by LEFsE analysis plotted as log10 relative abundance + 0.01 and across the three 420 groups. Horizontal black bars represent the mean of each group with whisker the SEM. 421

Significance for panels B-H was determined using Kruskal Wallis non-parametric ANOVA, with 422

Dunn's multiple comparison * = p < 0.05, ** = p <0.01, *** = p < 0.001, **** = p < 0.0001. Figure 5B , variants of 465 concern (P. 1, B.1.1.7, B.1.351, B.1.427 ATP1A1  ATP2A3  CD36  CD59  CD9  CLCN3  DNAH10  DNAH11  DNAH3  DNAH7  DNHD1  DYNC2H1  FER1L5  FZD6  HSF4  HSP90B1  ITGA3  ITGAV  ITGB1  LAMA2  LAMB2  LAMB3  LAMC2  PROS1  SLC1A1  SLC39A6  SLC39A7  SLC44A4  SLC4A8  TSPAN8  WDR19  WDR35   -2  0  1  2  -1   Row Z-score   BCL2  BCL3  C1QA  C3AR1  CCL4  CCL5  CCR1  CD53  COX2  CSF1  DDIT3  FCER1G  FCGR3B  FGD2  HLA-DPA1  HLA-DPB1  IKZF1  IKZF3  IRF1  IRF7  JAK3  JUN  LCK  LCP1  LGALS1  LGALS9  NUPR1  MYD88  MYO1G  RELB  SLAMF7  SOCS1  STAT1  TNFSF13B ZAP70 ZBP1

CoV-HCW CoV+ patient upregulated DEGs Figure S2 

UniFrac: an effective 576 distance metric for microbial community comparison

VEGAN, a package of R functions for community ecology

Metagenomic biomarker discovery and explanation

systemPipeR: NGS workflow and report generation environment

Metascape provides a biologist-oriented resource for the analysis of 583 systems-level datasets

Hospital-Acquired Infections in Critically Ill Patients With COVID-19

The loss of topography in the microbial communities of the upper 587 respiratory tract in the elderly

The nasal cavity microbiota of 589 healthy adults

Culture and molecular-based profiles show shifts in bacterial 591 communities of the upper respiratory tract that occur with age

The infant nasopharyngeal microbiome impacts severity of lower 594 respiratory infection and risk of asthma development

The respiratory microbiome and susceptibility to influenza virus 597 infection

The nasopharyngeal microbiota in patients with viral respiratory tract 599 infections is enriched in bacterial pathogens

High nasopharyngeal pneumococcal density, increased by viral 602 coinfection, is associated with invasive pneumococcal pneumonia

Temporal association between human upper respiratory and gut bacterial 605 microbiomes during the course of COVID-19 in adults

Microbiome disturbance and resilience dynamics of the upper respiratory 607 tract during influenza A virus infection

Inflammation: A Double-Edged Sword in the Response to 609 Pseudomonas aeruginosa Infection

Airway immunometabolites fuel Pseudomonas aeruginosa 611 infection

COVID-19 with Different Severities: A Multicenter Study of Clinical 613 Features

The Unrecognized Threat of Secondary Bacterial Infections 615 with COVID-19

Clinical course and risk factors for mortality of adult inpatients with 617 COVID-19 in Wuhan, China: a retrospective cohort study

Risks and features of secondary infections in severe and critical ill 620 COVID-19 patients

The role of the intensive care unit environment and health-care 622 workers in the transmission of bacteria associated with hospital acquired infections

The Microbiome of the Nose-Friend or Foe?

Nasal carriage of methicillin resistant 627 Staphylococcus aureus among health care workers at Al Shifa hospital in Gaza Strip

Long-term colonization of the cystic fibrosis lung by Burkholderia 630 cepacia complex bacteria: epidemiology, clonal variation, and genome-wide expression 631 alterations

Impact of Burkholderia dolosa on lung function and survival in cystic 633 fibrosis

A 17-Year Nationwide Study of Burkholderia cepacia 635

Complex Bloodstream Infections Among Patients in the United States Veterans Health 636 Administration

Shotgun transcriptome, spatial omics, and isothermal profiling of SARS-638

CoV-2 infection reveals unique host responses, viral diversification, and drug 639 interactions

Transcriptome of nasopharyngeal samples from COVID-19 patients and a 641 comparative analysis with other SARS-CoV-2 infection models reveal disparate host 642 responses against SARS-CoV-2

In vivo antiviral host transcriptional response to SARS-CoV-2 644 by viral load, sex, and age

A diagnostic host response biosignature for COVID-19 from RNA profiling 646 of nasal swabs and blood

COVID-19-related anosmia is associated with viral persistence and 648 inflammation in human olfactory epithelium and brain infection in hamsters

Emerging SARS-CoV-2 Variants and Impact in 651

Global Vaccination Programs against SARS-CoV-2/COVID-19. Vaccines (Basel)

Emergence of a Novel SARS-CoV-2 Variant in Southern California